- Research note
- Open Access
Prevalence of 3.7 and 4.2 deletions in Sudanese patients with red cells hypochromia and microcytosis
BMC Research Notes volume 13, Article number: 65 (2020)
Alpha-thalassemia is a genetic disorder characterized by deletions of one or more α globin genes that result in deficient of α globin chains reducing haemoglobin concentration. The study aimed to screen 97 patients with microcytosis and hypochromasia for the 3.7 and 4.2 alpha thalassemia deletion mutations.
Out of 97 patients screened, only 7 were carriers for the 3.7 deletion and all patients were negative for the 4.2 deletion. The 3.7 deletion was found in Foor, Hawsa and Rezagat Sudanese tribes. In the carriers of the 3.7 deletion, Red Blood Cells and Haematocrit were significantly increased. The Red Blood Cells were 7.23 ± 0.78 × 1012/L in adult males and 7.21 ± 0.67 × 1012/L in adult females while in children were 5.07 ± 0.87 × 1012/L. The mean cell volume and mean cell haemoglobin were significantly decreased, but the mean cell haemoglobin concentration slightly decreased. Haemoglobin levels didn’t revealed statistically significant decrease in adult males (11.7 ± 0.57 g/dL) and adult females (11.25 ± 0.64 g/dL), while in children were (11.6 ± 2.95 g/dL). Haemoglobin electrophoresis revealed two patients of the 3.7 and 4.2 negative were carriers for β-thalassemia. The study concluded that α3.7 deletion has frequency of 0.07 in Sudanese with hypochromasia and microcytosis.
Thalassemia is a hereditary blood disorder in which there is impaired synthesis of one or more globin chains of haemoglobin [1, 2]. Thalassemia syndromes can be conveniently classified according to the type of globin chain affected. Of these, there are two which are of special importance; they are called α-thalassemia and β-thalassemia. Others such as δβ, γδβ, δ, γ and εγδβ thalassemia are rare. Unlike β-thalassemia, the most common molecular defects in alpha thalassemia is due to large deletions involving either or both HBA1 and HBA2 genes. Most commonly recognised two α-globin gene deletions are --SEA, --FIL, --MED and --THAI, while common single α-globin gene deletions are − α3.7 and − α4.2. Less frequently, α-thalassemia results from single-nucleotide variants. Historically, the distribution of α-thalassemia follows a pattern consistent with the degree of malaria endemicity and shows a highest prevalence in Africa with an allele frequency of 0.3–0.4 for − α3.7 deletion. Alpha thalassemia is also common in Southeast Asian countries like Thailand, Laos, and Vietnam [3, 4]. The α-thalassemia has a wide range of distribution globally, so annually 300,000 thalassemia patients are born. It affects 5–40% of the population in Africa and 40–80% in South Asia [3, 5]. The prevalence and frequency of the disease into an increase globally because of the migration worldwide .
Although the incidence and prevalence of alpha thalassemia is known to be increased in the African countries, its exact incidence or prevalence in Sudanese remains unknown, so we hypothesized there are many asymptomatic carriers for alpha thalassemia mutations masked in Sudanese community.
This is a cross sectional study, aimed to determine most common types of alpha thalassemia mutations in Africans (3.7 and 4.2 deletion mutations) on molecular basis and to correlate the finding with haematological parameters. Blood samples were analyzed at the Biotechnology Research Laboratory, Ahfad University and the department of Molecular Biology, Institute of Endemic Diseases, University of Khartoum. A total number of 97 patients with age ranged between 12 and 63 years old attended the clinical laboratories of six hospitals in Khartoum City (Khartoum Teaching Hospital, Omdurman Maternity Hospital, Gafer Ibn Oaf Paediatric Hospital, Mohamed Elamin Hamid Paediatric Hospital, Omdurman Teaching Hospital and Albuluk Paediatric Hospital) for routine check-up, were randomly selected on bases of the microcytosis (MCV < 80 fL in adults or < 75 fL in children), hypochromasia (MCH < 27 pg), normal ferritin level to exclude iron deficiency anaemia, no history and currently free of malaria infection and chronic disorders. Data were collected by observation of laboratory investigations and a well-designed questionnaire used for data collection. Complete blood counting was done using an automatic multi-parameter Haematology Analyzer (Sysmex kx-21) for in vitro diagnostic in the clinical laboratories in-order to detect the abnormalities. Alkaline haemoglobin electrophoresis method was carried out to detect the coinheritance of hemoglobinopathy mainly the sickle cell anaemia, heterozygous B-thalassemia, Hb H or Hb Barts, using SAS-MX Alkaline Hb-10 kit (Helena Bioscience Europe), then the types and percent of Hb were measured by densitometry method. Ferritin level was measured using full automated Cobas e411 (Roche, German) . The genomic DNA was extracted using genomic DNA purification kit for whole blood (Jena Bioscience, Germany). The quantity and quality of extracted DNA was measured by a Nanodrope Spectrophotometer ND1000. Single tube multiplex Gap-PCR was done to screen all the 97 patients for the presence of the − α3.7 and − α4.2 deletions using the Platinum Multiplex PCR Master Mix (Invitrogen Applied Biosystem USA). The set of the primers used were supplied by Invitrogen Applied Biosystem, Germany). The sequence of the primers used were according to Chong . A large (2.5 kilo base) region of the LIS1 gene (Lissencephaly 1gene) was co-amplified as an internal PCR control. Positive control genomic DNA samples were kindly provided by the Medical Research Institute—Kuala Lumpur, Malaysia. All data were analysed by SPSS version 14 and the p. values were calculated by paired sample t test.
Before starting all reagents were allowed to thaw at room temperature, gently mixed by tube inverting and spin down. The reaction mixes were prepared according to the Platinum Multiplex PCR Master Mix manufacturer guidelines,  so each 25 uL reaction mix contained 12.5 uL Platinum Multiplex PCR Master Mix (2×), 5 uL GC enhancer (2×), 3.25 uL Primer Mix, 1 uL DNA (100 ng/uL) and 3.25 uL of Nuclease-free water. Senso Quest labcycler 48 (Germany) was used for PCR amplification with the initial denaturation at 95 °C for 5 min, followed by followed by 30 cycles of denaturation at 97 °C for 45 s, annealing at 60 °C for 1 min 15 s and 72 °C for 2 min 30 s, with a final extension at 72 °C for 5 min. PCR amplicons were analysed by electrophoresis on 1% agarose gel dissolved in 1 × Tris–Borate-EDTA buffer at 90 volts (current 40 amperes) for 2 h. The gels were stained and visualised under UV light.
A total number of 97 patients were enrolled in the study, 67 of them were children (12–17 years old) including (30 males and 37 females) and 30 adults (18–63 years old) including (12 males and 18 females). All patients were Sudanese distributed in 36 Sudanese Tribes. On basis of the molecular biology investigations, 7 out of 97 individuals presented heterozygous − α3.7 deletion, while none was positive for − α4.2 deletion (Fig. 1) and these 7 carriers were belong to tribes of Foor, Hawsa and Rezagat that originated from West Africa.
The means of RBCs count for carriers were significantly increased in adult males and females (7.23 ± 0.78 × 1012/L and 7.21 ± 0.67 × 1012/L, respectively) while were normal (5.06 ± 0.87 × 1012/L) in children. Hb level was mildly decreased; which were 11.70 ± 0.57 g/dL, 11.25 ± 0.64 g/dL and 11.6 ± 2.95 g/dL in males, females and children, respectively. The means of haematocrit (HCT) were 38.70 ± 3.25%, 37.65 ± 2.33% and 35.06 ± 7.38% in males, females and children, respectively. MCV in adults was clearly decreased; 53.60 ± 1.27 fL, and 52.35 ± 1.63 fL in males and females, while in children was 69.20 ± 7.49 fL. MCH was 16.25 ± 0.92 pg, 15.60 ± 0.57 pg and 22.80 ± 3.44 pg in males, females and children, respectively. MCHC was 30.25 ± 1.06%, 29.90 ± 0.14% and 32.86 ± 1.64% in males, females and children, respectively. The means RDW_CV were 20.20 ± 1.70% and 21.05 ± 0.07% in the adults (males and females respectively) and in children were 14.86 ± 0.95%. The types of haemoglobin in the study population according to the electrophoresis result revealed, 2 beta thalassemia trait patients, have increased Hb A2 (˃ 3.5%), 11 patients have Hb AS and 77 patients have normal haemoglobin (Hb AA) and no other haemoglobin variants detected. All carriers have normal haemoglobin (Hb AA) and no Hb H or Hb Barts were found (Table 1).
Globally, the frequency of alpha-thalassemia is low, but in some tropical and subtropical areas the frequency of carriers could be high (80–90%). However, the disease is unexplored in Sudanese, mainly because of the limited accessibility to molecular diagnostic facilities in the country [10,11,12,13]. In this study we report that at least 7% of hypochromic microcytic anaemia patients were carriers of − α3.7 deletion. Since incidence and prevalence of this syndrome was not well described in local population, it is extremely likely that α-thalassaemia triat may have been confused with iron deficiency state, especially if it was not assessed [14,15,16,17].
The RBCs in adult carriers showed a significant increase in counting with significant association with the mutation “P value < 0.05”, while in the children they were normal in count. The increase of RBCs count can be considered as a matter of compensation, a finding that have been reported before [18,19,20]. The haemoglobin concentration revealed mild anaemia in adults and children. This was previously reported , where alpha thalassemia trait patients were characterized by slight reduction in haemoglobin level. The MCV and MCH showed microcytosis and hypochromasia in adults, and this finding is consistent with many previous studies concerning the contribution of alpha thalassemia to microcytosis and hypochromia [20,21,22,23,24,25,26,27], while others [14, 28] reported slight microcytosis and hypochromasia or sometimes normal with alpha thalassemia trait. Unlike many other similar studies that have examined the red cell indices in alpha thalassaemia, present cohort showed significantly lower MCV (52–53 fL) giving an impression of additional pathology. The marked reduced MCV in the adult group, irrespective of their alpha thalassaemia carrier status, could be caused by the effect of coincidental chronic infection leading to anaemia of chronic disease.
The severe microcytosis and hypochromasia that is reported here might also be due to a coinheritance of the α3.7 allele with other deletion type or point mutation, such as AC deletion in vicinity of the initiation codon of the − α3.7 allele . RDW_CV of the − α3.7 heterozygous group revealed anisopoikilocytosis, in adult males and females, while in children showed mild anisopoikilocytosis, this finding is consistent with previous studies [27, 30, 31].
The observed absence of − α4.2 deletion in this study does not completely rule out the presence of α+ thalassaemia in the general population as this study only focused on hypochromic microcytic anaemia patients. Since heterozygous α+ thalassaemia may have a completely normal blood count or trivial hypochromia and anaemia, more inclusive study is required to confirm the observation.
In conclusion we confirm the presence of α3.7 allele in Sudanese with marked microcytosis and hypochromasia, where the disease was unknown before. This suggests that, previous migration from West Africa crossing Sudan was the main cause of transmission of such type of mutation in Sudanese.
The negativity of type 4.2 deletion don’t exclude the presence of this type of mutation in Sudanese, so further studies should be done including large number of population from different sites to screen for phenotypes and genotypes types of alpha thalassemia among Sudanese in the future.
Availability of data and materials
All data generated or analyzed in this study are included in this manuscript.
Complete blood count
Gram per dice liter
Gram per liter
- Hb A2 :
- Hb F:
Hemoglobin constant spring
Kilo base pare
Mean cell haemoglobin
Mean cell haemoglobin concentration
Mean cell volume
Polymerase chain reaction
Red blood cells
Red cell distribution width coefficient variation
Statistical Package for Social Studies
United State of America
White blood cells
World health organization
Kumar V, Abbas AK, Fausto N, Aster JC. Robbins and Cotran pathologic basis of disease, professional edition e-book. St. Louis: Elsevier health sciences; 2014.
Rubin R, Strayer DS, Rubin E, editors. Rubin’s pathology: clinicopathologic foundations of medicine. Philadelphia: Lippincott Williams & Wilkins; 2008.
Porwit A, McCullough J, Erber WN. Blood and bone marrow pathology e-book. St. Louis: Elsevier Health Sciences; 2011.
Coleman WB, Tsongalis GJ, editors. Essential concepts in molecular pathology. San Diego: Academic Press; 2010.
Weatherall DJ, Clegg JB. The thalassaemia syndromes. New York: Wiley; 2008.
Liu YT, Old JM, Miles K, Fisher CA, Weatherall DJ, Clegg JB. Rapid detection of alpha-thalassaemia deletions and alpha-globin gene triplication by multiplex polymerase chain reactions. Br J Haematol. 2000;108(2):295–9.
Roche (Cobas e411). Electrochemiluminescence immunoassay (ECLIA) for the in vitro quantitative determination of ferritin in human serum or plasma. http://www.rochediagnostics.ch/content/dam/corporate/rochedia_ch/documents/broschueren/professional_diagnostics/serumarbeitsplatz/immunologie/anamie/DE_Anemia_Factsheet_Ferritin.pdf.
Chong SS, Boehm CD, Higgs DR, Cutting GR. Single-tube multiplex-PCR screen for common deletional determinants of α-thalassemia. Blood. 2000;95(1):360–2.
Applied Biosystem USA. Platinum® Multiplex PCR Master Mix. https://tools.thermofisher.com/content/sfs/manuals/4463722A.pdf. Accessed Apr 2011.
Elderdery AY, Mohamed BA, Cooper AJ, Knight G, Mills J. Tribal distribution of haemoglobinopathies in a Sudanese patient population. J Med Lab Diagn. 2011;2(4):31–7.
Higgs DR. Molecular mechanisms of alpha thalassemia. In: Steinberg MH, Forget PG, Higgs DR, Nagel RL, editors. Disorders of Hemoglobin. Cambridge: Cambridge University Press; 2001. p. 405–30.
Modiano G, Morpurgo G, Terrenato L, Novelletto A, Di Rienzo A, Colombo B, Purpura M, Mariani M, Santachiara-Benerecetti S, Brega A, Dixit KA. Protection against malaria morbidity: near-fixation of the α-thalassemia gene in a Nepalese population. Am J Hum Genet. 1991;48(2):390.
DeLoughery TG. Microcytic anemia. N Engl J Med. 2014;371(14):1324–31.
Higgs DR. The molecular basis of α-thalassemia. Cold Spring Harb Perspect Med. 2013;3(1):a011718.
Matos JF, Borges KB, Fernandes AP, Faria JR, Carvalho MD. RDW as differential parameter between microcytic anemias in” pure” and concomitant forms. Jornal Brasileiro de Patologia e Medicina Laboratorial. 2015;51(1):22–7.
Pearson HA, Ehrenkranz RA, Rinder HM, Riely CA. Hemosiderosis in a normal child secondary to oral iron medication. Pediatrics. 2000;105(2):429–30.
El-Kalla S, Baysal E. α-thalassemia in the United Arab Emirates. Acta Haematol. 1998;100(1):49–53.
Mwakasungula S, Schindler T, Jongo S, Moreno E, Kamaka K, Mohammed M, Joseph S, Rashid R, Athuman T, Tumbo AM, Hamad A. Red blood cell indices and prevalence of hemoglobinopathies and glucose 6 phosphate dehydrogenase deficiencies in male Tanzanian residents of Dar es Salaam. Int J Mol Epidemiol Genet. 2014;5(4):185.
Guimarães JS, Cominal JG, Silva-Pinto AC, Olbina G, Ginzburg YZ, Nandi V, Westerman M, Rivella S, de Souza AM. Altered erythropoiesis and iron metabolism in carriers of thalassemia. Eur J Haematol. 2015;94(6):511–8.
Akhavan-Niaki H, Kamangari RY, Banihashemi A, Oskooei VK, Azizi M, Tamaddoni A, Sedaghat S, Vakili M, Nesheli HM, Shabani S. Hematologic features of alpha thalassemia carriers. Int J Mol Cell Med. 2012;1(3):162.
Borges E, Wenning MR, Kimura EM, Gervásio SA, Costa FF, Sonati MF. High prevalence of alpha-thalassemia among individuals with microcytosis and hypochromia without anemia. Braz J Med Biol Res. 2001;34(6):759–62.
Sankar VH, Arya V, Tewari D, Gupta UR, Pradhan M, Agarwal S. Genotyping of alpha-thalassemia in microcytic hypochromic anemia patients from North India. J Appl Genet. 2006;47(4):391–5.
Rahim F. Microcytic hypochromic anemia patients with thalassemia: genotyping approach. Indian J Med Sci. 2009;63(3):101–8.
Bezerra CM, Meissner RV. Diagnóstico molecular da talassemia alfa + (deleção-α3.7) em indivíduos com microcitose e/ou hipocromia atendidos no Hemocentro Dalton Barbosa Cunha em Natal, Rio Grande do Norte. Rev Bras Hematol Hemoter. 2010;32:90–1.
Wagner SC, Castro SM, Gonzalez TP, Santin AP, Filippon L, Zaleski CF, Azevedo LA, Amorin B, Callegari-Jacques SM, Hutz MH. Prevalence of common α-thalassemia determinants in south Brazil: importance for the diagnosis of microcytic anemia. Genet Mol Biol. 2010;33(4):641–5.
Azma RZ, Othman A, Azman N, Alauddin H, Ithnin A, Yusof N, Razak NF, Sardi NH, Hussin NH. Co-inheritance of compound heterozygous Hb Constant Spring and a single–α 3.7 gene deletion with heterozygous δβ thalassaemia: a diagnostic challenge. Malays J Pathol. 2012;34(1):57–62.
Sharma M, Pandey S, Ranjan R, Seth T, Saxena R. Prevalence of alpha thalassemia in microcytic anemia: a tertiary care experience from North India. Mediterr J Hematol Infect Dis. 2015;7(1):e2015004.
Higgs DR, Vickers MA, Wilkie AO, Pretorius IM, Jarman AP, Weatherall DJ. A review of the molecular genetics of the human alpha-globin gene cluster. Blood. 1989;73(5):1081–104.
Viprakasit V, Ayyub H, May A. Dinucleotide deletion in − α3.7 allele causes a severe form of α+ thalassaemia. Eur J Haematol. 2003;71(2):133–6.
Vayá A, Suescun M, Hernández JL, Pérez ML, Palanca S, Laiz B. Rheological red blood cell behaviour in minor α-thalassaemia carriers. Clin Hemorheol Microcirc. 2011;48(4):241–6.
Ahmad R, Saleem M, Aloysious N, Yelumalai P, Mohamed N, Hassan S. Distribution of alpha thalassaemia gene variants in diverse ethnic populations in Malaysia: data from the Institute for Medical Research. Int J Mol Sci. 2013;14(9):18599–614.
We would like to thank the families and patients for their cooperation and acceptance to participate in the study and we would like also to thank the research team at Institute for Medical Research, Jalan Pahang, Kuala Lumpur, Malaysia for their technical support and providing us with the DNA control samples. Also our deep thanks extend for the medical staff in Khartoum Hospital, Omdurman Maternity Hospital, Gafer Ibn Oaf Pediatric Hospital,Mohamed El Amin Pediatric Hospital in Omdurman. Omdurman Hospital and AlbulukPediatric Hospital for their cooperation. This work was funded by Ahfad University for Women. The fund covered all expenses of blood sample collection, reagents/chemicals, transportation and the data analysis. We would like to thank Ahfad University for Women for the financial support.
This work was funded by Ahfad University for Women. The fund covered all expenses of blood sample collection, reagents/chemicals, transportation and the data analysis.
Ethics approval and consent to participate
The ethical approval was obtained from ethical research committee of the faculty of Medicine, Alneelain University and approved by the Federal Ministry of Health in Sudan. Consents were signed by all adult participants’ and also the children patients has given parental consent for the study prior to enrolment and used achieved blood samples collected for complete blood counts (CBC) requested by the physician (non-probability sampling).
Consent for publication
The authors declare that they have no competing interests.
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
About this article
Cite this article
Osman, H.A., Hamid, M.M.A., Ahmad, R.B. et al. Prevalence of 3.7 and 4.2 deletions in Sudanese patients with red cells hypochromia and microcytosis. BMC Res Notes 13, 65 (2020). https://0-doi-org.brum.beds.ac.uk/10.1186/s13104-020-4933-5
- Alpha thalassemia
- Multiplex Gap-PCR
- Deletion mutations